Arcus’s highest priority is to execute on its ongoing Phase 3 trial and overall development plan aimed at establishing casdatifan as the standard-of-care and backbone therapy for clear cell renal cell ...

Veteran trial lawyer among 102 attorneys honored nationwide for 2026HOUSTON--(BUSINESS WIRE)--Iconic Houston trial lawyer Mark Lanier has been inducted into the Lawdragon Hall of Fame class of ...

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Myeloproliferative Neoplasms ORLANDO, FLORIDA / ACCESS Newswire / January 7, 2026 / The Assistance Fund, an ...

Number of Lawsuits Increases Fivefold to Over 2,100 Since May- FDA Approves Brain Tumour WarningGlobal pharmaceutical company Pfizer Inc. (NYSE: PFE), manufacturer of contraceptive injection ...

Approximately 60% of women will experience a UTI in their lifetime2 — Flush Advanced+ helps to reduce the risk of recurrent ...

The "TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook 2026" report has been added to ResearchAndMarkets.com's offering.This report tracks developments currently taking place ...

Expands Pain Management Portfolio with Next-Generation Topical NSAID TherapyRALEIGH, N.C.--(BUSINESS WIRE)--Acertis Pharmaceuticals, a specialty pharmaceutical company focused on delivering ...

Service expansions accelerate pharmacy’s achievement of 2 million shipments while maintaining industry-leading patient ...

Sterne, Kessler, Goldstein & Fox proudly announces the election of three new directors effective January 1, 2026. The newly promoted directors are Brian Dudley, Brady Gleason, and Melissa ...

Locus Biosciences today announced a contract award from the National Institute of Allergy and Infectious Diseases (NIAID), ...

New members bring deep experience in pancreatic, colorectal, and anal cancers to guide pelareorep’s development as a platform immunotherapy across GI tumorsCompany continues to strengthen its clinical ...

Supports Genmab’s ambition to build an AI-enabled innovation model that advances the company’s vision of bringing transformative antibody medicines to patientsCOPENHAGEN, Denmark--(BUSINESS WIRE)--#AI ...